Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease (2009)
Source: European Archives of Psychiatry and Clinical Neurosciences. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER (TERAPIA), LÍTIO (APLICAÇÕES TERAPÊUTICAS), PROTEÍNAS QUINASES (ANÁLISE;METABOLISMO)
ABNT
MENDES, Camila Teixeira et al. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. European Archives of Psychiatry and Clinical Neurosciences, v. 259, n. 1, p. 16-22, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00406-008-0828-5. Acesso em: 20 set. 2024.APA
Mendes, C. T., Mury, F. B., Moreira, E. de S., Alberto, F. L., Forlenza, O. V., Dias Neto, E., & Gattaz, W. F. (2009). Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. European Archives of Psychiatry and Clinical Neurosciences, 259( 1), 16-22. doi:10.1007/s00406-008-0828-5NLM
Mendes CT, Mury FB, Moreira E de S, Alberto FL, Forlenza OV, Dias Neto E, Gattaz WF. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 1): 16-22.[citado 2024 set. 20 ] Available from: https://doi.org/10.1007/s00406-008-0828-5Vancouver
Mendes CT, Mury FB, Moreira E de S, Alberto FL, Forlenza OV, Dias Neto E, Gattaz WF. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 1): 16-22.[citado 2024 set. 20 ] Available from: https://doi.org/10.1007/s00406-008-0828-5